IL6 and endometrial cancer: By sub-dividing the patients according to endometrial cancer subtypes, we found that among the type I endometrial cancer patients, BMI, leptin, and IL-6 significantly correlated with T status, N status, and the presence of distant metastases (stage IV) (Table 7).